Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24504 | 259 | 18.8 | 34% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BENZODIAZEPINOOXAZOLE | Author keyword | 3 | 100% | 1% | 3 |
2 | DAYA DRUG DISCOVERIES INC | Address | 3 | 100% | 1% | 3 |
3 | PHARM NAKA KU | Address | 3 | 50% | 2% | 4 |
4 | PHARMACEUT SCI 31 TANABE DORI MIZUHO KU | Address | 2 | 27% | 3% | 8 |
5 | 2175 MATSUBARA NAKA KU | Address | 1 | 100% | 1% | 2 |
6 | NIPPON TELEG TEL PUBL CORP NAKA KU | Address | 1 | 100% | 1% | 2 |
7 | CIENCIAS QUIM ANALIT DO 644 | Address | 1 | 40% | 1% | 2 |
8 | 1 4 BENZODIAZEPINE | Author keyword | 1 | 18% | 2% | 4 |
9 | CUI AND CUII COMPLEXES | Author keyword | 1 | 50% | 0% | 1 |
10 | ELECTRON CONFORMATIONAL APPROACH | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 1 4 BENZODIAZEPINE DRUGS | 12 | 86% | 2% | 6 |
2 | OXAZOLAM | 8 | 100% | 2% | 5 |
3 | BENZODIAZEPINOOXAZOLES | 4 | 75% | 1% | 3 |
4 | MEDAZEPAM | 4 | 75% | 1% | 3 |
5 | 11B METHYLBENZODIAZEPINOOXAZOLES | 3 | 100% | 1% | 3 |
6 | ANXIOLITIC DRUGS | 3 | 100% | 1% | 3 |
7 | CYCLOMETALLATED DERIVATIVES | 2 | 67% | 1% | 2 |
8 | PROTON EXCHANGE REACTION | 2 | 67% | 1% | 2 |
9 | 1 4 BENZODIAZEPIN 2 ONES | 2 | 28% | 2% | 5 |
10 | BROMAZEPAN | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
THE BENZODIAZEPINES | 1983 | 41 | 55 | 24% |
METHODS OF MULTI-CENTER TRIALS IN PSYCHIATRY .1. REVIEW | 1980 | 0 | 1 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DAYA DRUG DISCOVERIES INC | 3 | 100% | 1.2% | 3 |
2 | PHARM NAKA KU | 3 | 50% | 1.5% | 4 |
3 | PHARMACEUT SCI 31 TANABE DORI MIZUHO KU | 2 | 27% | 3.1% | 8 |
4 | 2175 MATSUBARA NAKA KU | 1 | 100% | 0.8% | 2 |
5 | NIPPON TELEG TEL PUBL CORP NAKA KU | 1 | 100% | 0.8% | 2 |
6 | CIENCIAS QUIM ANALIT DO 644 | 1 | 40% | 0.8% | 2 |
7 | CNR DIPARTIMENTO CHIM INORGAN MET ORGAN | 0 | 33% | 0.4% | 1 |
8 | SCI METHODES SEPARAT EA 3233 | 0 | 33% | 0.4% | 1 |
9 | DIPARTMENTO CHIM STRUTTURALE STEREOCHIM INORGAN | 0 | 20% | 0.4% | 1 |
10 | PL SCI BIOTECHNOL | 0 | 17% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189494 | ALKOXYCOUMARIN DEALKYLASE//PHENAZEPAM//GIDAZEPAM |
2 | 0.0000163589 | 1 5 BENZODIAZEPINES//1 5 BENZODIAZEPINE//O PHENYLENEDIAMINES |
3 | 0.0000154438 | 7 AMINOFLUNITRAZEPAM//BROMAZEPAM//FLUNITRAZEPAM |
4 | 0.0000125034 | UNIFIED EQUATION//DYNAMIC CHROMATOGRAPHY//CHROMWIN |
5 | 0.0000121480 | EUHFC3//EUFOD3//ONE AND TWO DIMENSIONAL NMR |
6 | 0.0000114313 | 2 3 DIHYDRO 1 4 DIAZEPINES//2 BENZOYLPYRROLE//2 THIOURACIL DERIVATIVES |
7 | 0.0000094098 | PSEUDO BASE//REISSERT COMPOUND//FORMYLINDOLE |
8 | 0.0000091828 | PYRAZOLOTHIADIAZINES//HIV 1NNRTIS//ELEMENTORGAN CHEM |
9 | 0.0000091702 | DIHYDRODIPYRIDOPYRAZINES//SINTEZA ORGAN//ANALYT CHEM MED FYSIOCHEM |
10 | 0.0000077223 | PIPERAZINE AND PIPERAZIN 1 IUM LIGANDS//ANTIAGGREGATORY ACTIVITIES//PIPERAZINE COMPLEXES |